• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠肝脏中多药耐药相关蛋白2(Mrp2)药物转运功能的定量分析。

Quantification of drug transport function across the multiple resistance-associated protein 2 (Mrp2) in rat livers.

作者信息

Bonnaventure Pierre, Pastor Catherine M

机构信息

Universitaires de Genève, Geneva 1205, Switzerland.

出版信息

Int J Mol Sci. 2014 Dec 24;16(1):135-47. doi: 10.3390/ijms16010135.

DOI:10.3390/ijms16010135
PMID:25547484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4307239/
Abstract

To understand the transport function of drugs across the canalicular membrane of hepatocytes, it would be important to measure concentrations in hepatocytes and bile. However, these concentration gradients are rarely provided. The aim of the study is then to measure these concentrations and define parameters to quantify the canalicular transport of drugs through the multiple resistance associated-protein 2 (Mrp2) in entire rat livers. Besides drug bile excretion rates, we measured additional parameters to better define transport function across Mrp2: (1) Concentration gradients between hepatocyte and bile concentrations over time; and (2) a unique parameter (canalicular concentration ratio) that represents the slope of the non-linear regression curve between hepatocyte and bile concentrations. This information was obtained in isolated rat livers perfused with gadobenate dimeglumine (BOPTA) and mebrofenin (MEB), two hepatobiliary drugs used in clinical liver imaging. Interestingly, despite different transport characteristics including excretion rates into bile and hepatocyte clearance into bile, BOPTA and MEB have a similar canalicular concentration ratio. In contrast, the ratio was null when BOPTA was not excreted in bile in hepatocytes lacking Mrp2. The canalicular concentration ratio is more informative than bile excretion rates because it is independent of time, bile flows, and concentrations perfused in portal veins. It would be interesting to apply such information in human liver imaging where hepatobiliary compounds are increasingly investigated.

摘要

为了解药物跨肝细胞胆小管膜的转运功能,测定肝细胞和胆汁中的浓度很重要。然而,这些浓度梯度很少被提供。因此,本研究的目的是测定这些浓度,并确定参数以量化药物在整个大鼠肝脏中通过多药耐药相关蛋白2(Mrp2)的胆小管转运。除了药物胆汁排泄率外,我们还测量了其他参数以更好地定义跨Mrp2的转运功能:(1)肝细胞和胆汁浓度随时间的浓度梯度;(2)一个独特的参数(胆小管浓度比),它代表肝细胞和胆汁浓度之间非线性回归曲线的斜率。这些信息是在灌注了钆贝葡胺(BOPTA)和甲溴菲宁(MEB)的离体大鼠肝脏中获得的,这两种肝胆药物用于临床肝脏成像。有趣的是,尽管BOPTA和MEB具有不同的转运特征,包括胆汁排泄率和肝细胞向胆汁的清除率,但它们的胆小管浓度比相似。相比之下,在缺乏Mrp2的肝细胞中,当BOPTA不排泄到胆汁中时,该比值为零。胆小管浓度比比胆汁排泄率更具信息量,因为它与时间、胆汁流量和门静脉灌注浓度无关。将这些信息应用于越来越多地研究肝胆化合物的人体肝脏成像中将会很有趣。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/cf094163211a/ijms-16-00135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/2cc3aa8a2376/ijms-16-00135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/2604a4c1d590/ijms-16-00135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/2fa1ba92a663/ijms-16-00135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/cf094163211a/ijms-16-00135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/2cc3aa8a2376/ijms-16-00135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/2604a4c1d590/ijms-16-00135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/2fa1ba92a663/ijms-16-00135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431e/4307239/cf094163211a/ijms-16-00135-g004.jpg

相似文献

1
Quantification of drug transport function across the multiple resistance-associated protein 2 (Mrp2) in rat livers.大鼠肝脏中多药耐药相关蛋白2(Mrp2)药物转运功能的定量分析。
Int J Mol Sci. 2014 Dec 24;16(1):135-47. doi: 10.3390/ijms16010135.
2
How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver.在缺乏 Mrp2 的肝细胞中有机阴离子是如何积累的:大鼠肝脏的证据。
J Pharmacol Exp Ther. 2011 Mar;336(3):624-32. doi: 10.1124/jpet.110.175406. Epub 2010 Dec 2.
3
Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.肝脏灌注通过跨窦状膜的转运清除率改变钆喷酸葡胺和钆贝葡胺的肝细胞浓度。
Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):657-667. doi: 10.1007/s13318-016-0382-x.
4
Isolated Perfused Rat Livers to Quantify the Pharmacokinetics and Concentrations of Gd-BOPTA.使用离体灌流大鼠肝脏模型定量研究 Gd-BOPTA 的药代动力学和浓度。
Contrast Media Mol Imaging. 2018 Jul 11;2018:3839108. doi: 10.1155/2018/3839108. eCollection 2018.
5
Hepatocyte Concentrations of Imaging Compounds Associated with Transporter Inhibition: Evidence in Perfused Rat Livers.与转运蛋白抑制相关的显像化合物在肝细胞中的浓度:在灌注大鼠肝脏中的证据。
Drug Metab Dispos. 2019 Apr;47(4):412-418. doi: 10.1124/dmd.118.084624. Epub 2019 Jan 23.
6
Concentrations of Gd-BOPTA in cholestatic fatty rat livers: role of transport functions through membrane proteins.胆汁淤积性脂肪肝大鼠肝脏中 Gd-BOPTA 的浓度:膜蛋白转运功能的作用。
Contrast Media Mol Imaging. 2013 Mar-Apr;8(2):147-56. doi: 10.1002/cmmi.1511.
7
New Pharmacokinetic Parameters of Imaging Substrates Quantified from Rat Liver Compartments.从大鼠肝隔间定量成像底物的新药代动力学参数。
Drug Metab Dispos. 2022 Jan;50(1):58-64. doi: 10.1124/dmd.121.000546. Epub 2021 Oct 20.
8
Application of Pharmacokinetic Modeling to Characterize Hepatobiliary Disposition of Imaging Agents and Alterations due to Liver Injury in Isolated Perfused Rat Livers.应用药代动力学模型描述示踪剂在肝内的处置以及肝损伤对其在离体灌流大鼠肝脏中分布的影响。
Pharm Res. 2023 Nov;40(11):2513-2523. doi: 10.1007/s11095-023-03549-2. Epub 2023 Jun 22.
9
How transfer rates generate Gd-BOPTA concentrations in rat liver compartments: implications for clinical liver imaging with hepatobiliary contrast agents.转运速率如何在大鼠肝脏各部分产生钆贝葡胺浓度:对肝胆对比剂临床肝脏成像的启示。
Contrast Media Mol Imaging. 2016 Jul;11(4):291-8. doi: 10.1002/cmmi.1691. Epub 2016 Apr 5.
10
Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats.脂肪变性改变肥胖大鼠肝细胞膜转运体的活性。
Cells. 2021 Oct 13;10(10):2733. doi: 10.3390/cells10102733.

引用本文的文献

1
Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [Tc]mebrofenin Imaging in Rats.使用[锝]美罗芬宁成像在大鼠中验证用于靶向抑制肝细胞胆小管多药耐药相关蛋白2(MRP2)活性的药理学方案。
Pharmaceutics. 2020 May 27;12(6):486. doi: 10.3390/pharmaceutics12060486.
2
Isolated Perfused Rat Livers to Quantify the Pharmacokinetics and Concentrations of Gd-BOPTA.使用离体灌流大鼠肝脏模型定量研究 Gd-BOPTA 的药代动力学和浓度。
Contrast Media Mol Imaging. 2018 Jul 11;2018:3839108. doi: 10.1155/2018/3839108. eCollection 2018.
3
Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.

本文引用的文献

1
Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues.应用正电子发射断层扫描研究组织中转运体介导的药物相互作用。
Clin Pharmacol Ther. 2014 Aug;96(2):206-13. doi: 10.1038/clpt.2014.70. Epub 2014 Mar 28.
2
An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.一种使用Mrp2缺陷型TR大鼠三明治培养肝细胞并结合Bcrp基因敲低来评估转运功能受损对肝胆药物处置影响的实验方法。
Mol Pharm. 2014 Mar 3;11(3):766-75. doi: 10.1021/mp400471e. Epub 2014 Jan 30.
3
肝脏灌注通过跨窦状膜的转运清除率改变钆喷酸葡胺和钆贝葡胺的肝细胞浓度。
Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):657-667. doi: 10.1007/s13318-016-0382-x.
The role of organic anion transporters in diagnosing liver diseases by magnetic resonance imaging.
有机阴离子转运体在磁共振成像诊断肝脏疾病中的作用。
Drug Metab Dispos. 2014 Apr;42(4):675-84. doi: 10.1124/dmd.113.055707. Epub 2014 Jan 7.
4
Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics.肝脏外排转运体在调节异生物质的全身和肝细胞暴露中的作用。
Annu Rev Pharmacol Toxicol. 2014;54:509-35. doi: 10.1146/annurev-pharmtox-011613-140021. Epub 2013 Oct 23.
5
Bile formation and secretion.胆汁的形成和分泌。
Compr Physiol. 2013 Jul;3(3):1035-78. doi: 10.1002/cphy.c120027.
6
Imaging in the study of membrane transporters.膜转运蛋白研究中的成像技术。
Clin Pharmacol Ther. 2013 Jul;94(1):33-6. doi: 10.1038/clpt.2013.85. Epub 2013 Apr 24.
7
In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.在体可视化和定量研究 99mTc-美罗芬尼在小鼠肝摄取和 Mrp2 介导的胆排泄中的(紊乱)有机阴离子转运多肽介导作用。
J Nucl Med. 2013 Apr;54(4):624-30. doi: 10.2967/jnumed.112.108233. Epub 2013 Feb 25.
8
Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms.肝肠药物转运体:药物相互作用和遗传多态性引起的药代动力学效应预测。
Annu Rev Pharmacol Toxicol. 2013;53:581-612. doi: 10.1146/annurev-pharmtox-011112-140309. Epub 2012 Nov 8.
9
Troubleshooting and improving the mouse and rat isolated perfused liver preparation.解决小鼠和大鼠离体灌注肝脏制备过程中的问题并加以改进。
J Pharmacol Toxicol Methods. 2013 Mar-Apr;67(2):107-14. doi: 10.1016/j.vascn.2012.10.001. Epub 2012 Oct 16.
10
A perspective on efflux transport proteins in the liver.肝脏中外排转运蛋白的研究展望。
Clin Pharmacol Ther. 2012 Nov;92(5):599-612. doi: 10.1038/clpt.2012.79. Epub 2012 Sep 5.